Sustained safety and efficacy of once-daily hydromorphone extended-release (OROS® hydromorphone ER) compared with twice-daily oxycodone controlled-release over 52 weeks in patients with moderate to severe chronic noncancer pain. (Q48248784)

From Wikidata

Jump to navigation Jump to search

scientific article published on 18 April 2012

Language	Label	Description	Also known as
English	Sustained safety and efficacy of once-daily hydromorphone extended-release (OROS® hydromorphone ER) compared with twice-daily oxycodone controlled-release over 52 weeks in patients with moderate to severe chronic noncancer pain.	scientific article published on 18 April 2012

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22510252%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Sustained safety and efficacy of once-daily hydromorphone extended-release (OROS® hydromorphone ER) compared with twice-daily oxycodone controlled-release over 52 weeks in patients with moderate to severe chronic noncancer pain (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22510252%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Rainer Sabatowski

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22510252%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

author name string

Ute Richarz

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22510252%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Sandra Waechter

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22510252%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Leszek Szczepanski

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22510252%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Heinrich Binsfeld

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22510252%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

publication date

18 April 2012

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22510252%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22510252%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22510252%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22510252%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

30-40

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22510252%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2012.00553.X

21 January 2018

The impact of pain on quality of life and the unmet needs of pain management: results from pain sufferers and physicians participating in an Internet survey

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2012.00553.X

21 January 2018

The management of opioid-related sedation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2012.00553.X

21 January 2018

Establishing "best practices" for opioid rotation: conclusions of an expert panel

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2012.00553.X

21 January 2018

Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2012.00553.X

21 January 2018

Once-daily OROS hydromorphone ER compared with placebo in opioid-tolerant patients with chronic low back pain

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2012.00553.X

21 January 2018

Opioid rotation: the science and the limitations of the equianalgesic dose table

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2012.00553.X

21 January 2018

A systematic review of hydromorphone in acute and chronic pain.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2012.00553.X

21 January 2018

Input characteristics and bioavailability after administration of immediate and a new extended-release formulation of hydromorphone in healthy volunteers.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2012.00553.X

21 January 2018

Oxycodone: a review of its use in the management of pain

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2012.00553.X

21 January 2018

A randomized study to demonstrate noninferiority of once-daily OROS(®) hydromorphone with twice-daily sustained-release oxycodone for moderate to severe chronic noncancer pain.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2012.00553.X

21 January 2018

A randomized, double-blind comparison of OROS(R) hydromorphone and controlled-release morphine for the control of chronic cancer pain

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2012.00553.X

21 January 2018

An open-label, 1-year extension study of the long-term safety and efficacy of once-daily OROS(R) hydromorphone in patients with chronic cancer pain

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2012.00553.X

21 January 2018

A systematic review of the associations between dose regimens and medication compliance

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2012.00553.X

21 January 2018

Opioid rotation in patients with cancer pain. A retrospective comparison of dose ratios between methadone, hydromorphone, and morphine

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2012.00553.X

21 January 2018

Opioid pharmacotherapy in the management of cancer pain: a survey of strategies used by pain physicians for the selection of analgesic drugs and routes of administration

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2012.00553.X

21 January 2018

Efficacy and safety evaluation of once-daily OROS hydromorphone in patients with chronic low back pain: a pilot open-label study (DO-127).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2012.00553.X

21 January 2018

Open-label study on the long-term efficacy, safety, and impact on quality of life of OROS hydromorphone ER in patients with chronic low back pain

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2012.00553.X

21 January 2018

Double-blind, randomized comparison of the analgesic and pharmacokinetic profiles of controlled- and immediate-release oral oxycodone in cancer pain patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2012.00553.X

21 January 2018

Efficacy and tolerability of cancer pain management with controlled-release oxycodone tablets in opioid-naive cancer pain patients, starting with 5 mg tablets

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2012.00553.X

21 January 2018

Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2012.00553.X

21 January 2018

Controlled-release oxycodone for pain in diabetic neuropathy: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2012.00553.X

21 January 2018

Efficacy and safety of oxymorphone extended release in chronic low back pain: results of a randomized, double-blind, placebo- and active-controlled phase III study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2012.00553.X

21 January 2018

Hydromorphone for acute and chronic pain.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/citations/10.1002/14651858.CD003447

Identifiers

10.1111/J.1533-2500.2012.00553.X

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22510252%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22510252%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48248784&oldid=2224561115"